Company profile

Testmate Health SA

Testmate Health is developing the first disposable home test for common STIs. It is a urine based test for both men and women, and provides results in minutes for chlamydia, gonorrhoea & trichomoniasis. We combine key breakthrough technological innovations in urine handling & sample preparation, and low-cost colorimetric detection of DNA sequences to achieve our mission of making STI testing inclusive & accessible. Our technological platform provides PCR equivalent accuracy that overcomes urine sampling challenges, it can be performed in simple steps by any consumer, and the low cost structure allows for high market adoption.

More news about Testmate Health SA

14.12.2023 15:40

IMD reveals the 29 winners of the 2024 Startup Challenge

Please login or
register to use the
awards follow feature
06.12.2023 16:10

Prix Strategis 2024 Semi-finalists unveiled

Please login or
register to use the
awards follow feature
28.04.2023 15:06

Swiss Accelerator: Innosuisse supports 53 companies with CHF112 million

Please login or
register to use the
awards follow feature
02.03.2022 13:15

Testmate Health and Atinary Technologies get Biopôle funding

Please login or
register to use the
awards follow feature
13.01.2022 11:00

Ten startups to explore Africa

Please login or
register to use the
awards follow feature
17.06.2021 08:01

W. A. de Vigier prize for six startups

Please login or
register to use the
awards follow feature
23.04.2021 09:20

Tech4Eva draws global interest

Please login or
register to use the
awards follow feature
Testmate Health SA

Founded
2020

Kanton
VD


LinkedIn

Homepage

rss